Database : HANSEN
Search on : CERCOPITHECUS AETHIOPS [Subject descriptor]
References found : 2 [refine]
Displaying: 1 .. 2   in format [Detailed]

page 1 de 1

  1 / 2 HANSEN  
              next record last record
select
to print
Id:17687
Author:Tapinos, Nikos; Ohnishi, Makoto; Rambukkana, Anura
Title:ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli ..-
Source:s.l; s.n; 2006. 6 p. ilus, tab, graf.
Abstract:Demyelination is a common pathologic feature in many neurodegenerative diseases including infection with leprosy-causing Mycobacterium leprae. Because of the long incubation time and highly complex disease pathogenesis, the management of nerve damage in leprosy, as in other demyelinating diseases, is extremely difficult. Therefore, an important challenge in therapeutic interventions is to identify the molecular events that occur in the early phase before the progression of the disease. Here we provide evidence that M. leprae-induced demyelination is a result of direct bacterial ligation to and activation of ErbB2 receptor tyrosine kinase (RTK) signaling without ErbB2-ErbB3 heterodimerization, a previously unknown mechanism that bypasses the neuregulin-ErbB3-mediated ErbB2 phosphorylation. MEK-dependent Erk1 and Erk2 (hereafter referred to as Erk1/2) signaling is identified as a downstream target of M. leprae-induced ErbB2 activation that mediates demyelination. Herceptin (trastuzumab), a therapeutic humanized ErbB2-specific antibody, inhibits M. leprae binding to and activation of ErbB2 and Erk1/2 in human primary Schwann cells, and the blockade of ErbB2 activity by the small molecule dual ErbB1-ErbB2 kinase inhibitor PKI-166 (ref. 11) effectively abrogates M. leprae-induced myelin damage in in vitro and in vivo models. These results may have implications for the design of ErbB2 RTK-based therapies for both leprosy nerve damage and other demyelinating neurodegenerative diseases. (AU).
Descriptors:Anticorpos Monoclonais/PD
Butadienos/PD
Células COS
Células Cultivadas
Cercopithecus aethiops
Técnicas de Cocultura
Doenças Desmielinizantes/*ME/PA
Ativação Enzimática/DE
Inibidores Enzimáticos/PD
Células Hela
Hanseníase/*ME/MI
Camundongos Knockout
Proteína Quinase 1 Ativada por Mitógeno/ME
Proteína Quinase 3 Ativada por Mitógeno/ME
Mycobacterium leprae/GE/*ME
Nitrilos/PD
Pirimidinas/PD
Pirróis/PD
Receptor erbB-2/*ME
Research Support, N.I.H., Extramural
Células de Schwann/EN/ME
Nervo Ciático/ME/MI/UL
Transdução de Sinal
Limits:Ratos
Camundongos Nus
Camundongos
Humanos
Estudo Comparativo
Animais
Location:BR191.1; 09361/s


  2 / 2 HANSEN  
              first record previous record
select
to print
Id:9293
Author:Meyers, Wayne M; Gormus, Bobby J; Walsh, Gerald P; Baskin, Gary B; Hubbard, Gene B
Title:Naturally acquired and experimental leprosy nonhuman primates ..-
Source:s.l; s.n; 1991. 4 p. ilus.
Conference:Present in: Special Symposium on Hansen's Disease: Advances in Clinical and Experimental Research, Honolulu, 14 december 1989.
Descriptors:CERCOPITHECIDAE
CERCOPITHECUS AETHIOPS
MODELOS ANIMAIS DE DOENÇAS
HYLOBATES
HANSENIASE
MACACA MULATTA
DOENÇAS DOS MACACOS
PONGIDAE
Location:BR191.1; 06226/s; 06369/s



page 1 de 1
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information